PreveCeutical Medical Inc (PRVCF)

[lithiumjr]

PreveCeutical Begins Trading on the OTCQB


Vancouver, British Columbia--(Newsfile Corp. - September 18, 2017) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company's application to have its common shares listed on the OTCQB Venture Marketplace ("OTCQB") in the United States has been approved and that the Company's common share began trading on September 15, 2017, under the symbol "PRVCF".

The OTCQB is for early-stage and developing United States and international companies. To be eligible for trading, companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.

PreveCeutical's Chairman and CEO, Mr. Stephen Van Deventer commented, "We are extremely pleased to be able to upgrade to quote on the OTCQB. This listing will enable us to expand our U.S. shareholder base as well as offer the Company's existing U.S. shareholders a more transparent and efficient platform to obtain quotes and trade PreveCeutical securities."